Peptide Research & Insights

Evidence-based articles on peptide mechanisms, research findings and practical context — written to answer the questions researchers actually ask.

52Articles

0Topics

Aug 2026Last updated

SourcedCited research

Fat Loss

The Science Behind Retatrutide: A New Hope for Obesity and Diabetes

Retatrutide is an innovative triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, offering a promising approach for obesity and type 2...

Sep 7, 2025 · 5 min read

Benefits of Tirzepatide

The Science Behind Tirzepatide: GLP-1 and GIP Dual Action

Tirzepatide, a dual GIP/GLP-1 receptor agonist, helps regulate blood sugar and appetite, supporting weight loss, improved insulin sensitivity, and metabolic health. Prime...

Sep 7, 2025 · 6 min read

Notice

Strictly for research & development.

For laboratory research use only — please read before you order.

All products offered by Prime Lab Peptides are intended strictly for laboratory research and development purposes. These materials are not designed or approved for human or animal use, and must not be utilized for any diagnostic, therapeutic, or medical application.

Prime Lab Peptides does not provide instructions related to preparation, reconstitution, administration, injection, dosage, or any form of usage.

No product sold on this website is classified as a drug, dietary supplement, or medical device under federal law.

All items are labeled “For Research Use Only – Not for Human or Animal Use,” in accordance with 21 CFR 809.10(c) and other applicable regulations.

Any misuse, diversion, or unauthorized application is strictly prohibited and may violate federal, state, or international laws.

Prime Lab Peptides operates solely as a chemical and research material supplier. We are not a compounding pharmacy (503A) nor an outsourcing facility (503B) as defined under the Federal Food, Drug, and Cosmetic Act. Our products have not been evaluated by the U.S. Food & Drug Administration.

By purchasing from this website, you confirm that you are a qualified researcher or institution and accept full responsibility for the safe handling, storage, and use of these materials.

“Tirzepatide”, “Semaglutide”, and “Retatrutide” are recognized International Nonproprietary Names (INN) established by the World Health Organization. As such, these names are not subject to trademark protection and are used solely to identify the underlying chemical substances.